Form 8-K - Current report:
SEC Accession No. 0001021771-24-000166
Filing Date
2024-08-13
Accepted
2024-08-13 16:11:03
Documents
18
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SECOND QUARTER RESULTS brt81324.htm   iXBRL 8-K 26813
5 PRESS RELEASE RE SECOND QUARTER RESULTS ex99_1.htm EX-99.1 1814
6 brtpr_1.jpg GRAPHIC 887802
7 brtpr_2.jpg GRAPHIC 860447
8 brtpr_3.jpg GRAPHIC 1172232
9 brtpr_4.jpg GRAPHIC 227119
  Complete submission text file 0001021771-24-000166.txt   4498345

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brtx-20240813.xsd EX-101.SCH 3884
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20240813_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20240813_pre.xml EX-101.PRE 16057
20 EXTRACTED XBRL INSTANCE DOCUMENT brt81324_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 241201540
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)